Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
-
- A Rittmeyer
- Creator
Journal
-
- Lancet (London, England).
-
Lancet (London, England). 2016